KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Opko Health (OPK) Common Equity (2016 - 2025)

Opko Health's Common Equity history spans 16 years, with the latest figure at $1.3 billion for Q4 2025.

  • For Q4 2025, Common Equity fell 7.14% year-over-year to $1.3 billion; the TTM value through Dec 2025 reached $1.3 billion, down 7.14%, while the annual FY2025 figure was $1.3 billion, 7.14% down from the prior year.
  • Common Equity reached $1.3 billion in Q4 2025 per OPK's latest filing, down from $1.3 billion in the prior quarter.
  • In the past five years, Common Equity ranged from a high of $1.8 billion in Q3 2021 to a low of $1.3 billion in Q1 2024.
  • Average Common Equity over 5 years is $1.5 billion, with a median of $1.5 billion recorded in 2023.
  • Peak YoY movement for Common Equity: rose 9.71% in 2021, then fell 19.27% in 2024.
  • A 5-year view of Common Equity shows it stood at $1.7 billion in 2021, then fell by 7.33% to $1.6 billion in 2022, then decreased by 11.04% to $1.4 billion in 2023, then dropped by 1.71% to $1.4 billion in 2024, then fell by 7.14% to $1.3 billion in 2025.
  • Per Business Quant, the three most recent readings for OPK's Common Equity are $1.3 billion (Q4 2025), $1.3 billion (Q3 2025), and $1.3 billion (Q2 2025).